Skip to content

Clinical trials

Observational Adrenoleukodystrophy trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adrenoleukodystrophy Phase: Observational Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20163
20171
20182
20192
20201
20214
20221
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting9
Completed3
Terminated2
Unknown status2
Withdrawn2
Not yet recruiting1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Genetix Biotherapeutics Inc.3
Assistance Publique - Hôpitaux de Paris2
Children's Hospital of Philadelphia2
Masonic Cancer Center, University of Minnesota2
Beijing Tiantan Hospital1
Centre Hospitalier Universitaire de Liege1
Children's Hospital of Fudan University1
Fairview University Medical Center1
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta1
Leipzig University Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adrenoleukodystrophy20
Leukodystrophy, Metachromatic7
Leukodystrophy, Globoid Cell5
Leukoencephalopathies4
Peroxisomal Disorders4
Alexander Disease3
Charcot-Marie-Tooth Disease3
Gaucher Disease3
Metabolic Diseases3
Mucopolysaccharidoses3

Trials

Showing 26 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.